Facebook Pixel Code
About Sickkids
About SickKids

Brian Feldman, MD, MSc, FRCPC

The Hospital for Sick Children
Division Head
Rheumatology

Research Institute
Senior Scientist
Child Health Evaluative Sciences

University of Toronto
Professor
Department of Pediatrics & Medicine

Professor
Health Policy Management & Evaluation

Professor
Dalla Lana School of Public Health


Phone: 416-813-7654 ext. 28108
Fax: 416-813-4989
e-mail: brian.feldman@sickkids.ca

Brief Biography

Dr. Brian Feldman is Professor of Pediatrics, Medicine, Health Policy Management & Evaluation, and the Dalla Lana School of Public Health at the University of Toronto. He is Division Head of Rheumatology at The Hospital for Sick Children. Dr. Feldman graduated from the University of Western Ontario (MD, 1985) and he did further graduate training in clinical epidemiology at the University of Toronto (MSc, 1994). He interned at the Mount Sinai Hospital in Toronto and went on to do a core pediatric residency at the Children’s Hospital of Eastern Ontario. Dr. Feldman returned to Toronto to be an associate chief resident at The Hospital for Sick Children. He stayed on there to complete a fellowship in pediatric rheumatology.

Dr. Feldman’s main focus has been in clinical research in the field of childhood rheumatic disease. Recognizing the challenges involved in the study of rare disease Dr. Feldman has worked to improve the tools available to assist in this research. He has worked at developing and refining outcome measurement tools for use in clinical trials and in outcome studies. He has developed innovative methodologies for the study of new therapies (e.g. the Randomized Placebo Phase Design) and refined and tested powerful existing methods (e.g. Bayesian meta-analysis of n-of-1 randomized trials). Dr. Feldman has made contributions to the understanding of the prognosis and treatment of juvenile dermatomyositis, the cost-effective prevention of arthropathy in severe hemophilia, the course and outcome of systemic-onset juvenile idiopathic arthritis and juvenile SLE, and the role of fitness and exercise in childhood chronic diseases including arthritis and fibromyalgia.

Dr. Feldman’s research, by its nature, is collaborative. As such he is a member of the Pediatric Rheumatology Collaborative Study Group, the Canadian Alliance of Pediatric Rheumatology Investigators, the International Myositis Assessment Criteria study group, and other collaborative organizations. He was one of the founding members of the Childhood Arthritis and Rheumatology Research Alliance (CARRA), and was the head of the protocol evaluation subcommittee and chair of the Juvenile Dermatomyositis subcommittee.

Research Interests

  • Clinical trial design
  • Paediatric rheumatic diseases
  • Juvenile dermatomyositis

Research Activities

  • Clinical trials in childhood arthritis and cost-effectiveness of preventative therapy in hemophilia
  • Developing methodologies and measurement tools that allow for valid clinical treatment trials in subjects with rare diseases

External Funding

Senior Investigator's Name Appears in Bold

Towards Standards of Care for Juvenile Dermatomyositis (JDM): A CARRA JDM Committee Study.  Feldman B:  Childhood Arthritis and Rheumatology Research Alliance (CARRA).  ($54,945 2006 – 2007)

Moderate Term Musculoskeletal Outcomes with Escalating Dose Prophylaxis: the Canadian Hemophilia Prophylaxis Study Follow-up Study (CHPS-2).  Feldman, B: Bayer ($780,000 07/2006 – 12/2009)

Development and Usability and Feasibility Testing of a Web-Based Self-Management Program for Adolescents with Arthritis.  Feldman B, McGrath P, Stinson J: Networks of Centres of Excellence (NCE) ($69,350 05/2007 – 06/2009)

Development of a Feasible Tool to Measure Oral Mucositis in Children with Cancer.  Lillian Sung, Peter Judd, Deborah Tomlinson, John Doyle, Eleanor Hendershot Anne Marie Maloney, Brian Feldman: POGO: Pediatric Oncology Group of Ontario ($13,334 2007 - 2008)

Inflammation and Atherosclerosis in Paediatric Rheumatic Disease.  Bradley T, Beyene J, Schneider R, Feldman B, Silverman ED: Heart and Stroke Foundation of Ontario ($125,488 2007 - 2009)

Validation of Accelerometry as a Measure of Physical Activity and Inactivity in Children with Chronic Disease.  Feldman B, Stephens S, Takken T, Wright V, Tramblay M, Beyenne J, Biggar W, Esliger D, Longmuir P, McCrindle B, Schneiderman-Walker J, Van Der Net J: Canadian Institutes of Health Research ($64,985 2007 - 2008)

Effectiveness of Warfarin on Survival in Idiopathic and Scleroderma Associated Pulmonary Hypertension.  A Retrospective Cohort Study.  Johnson S, Feldman BM: The Arthritis Society - Scleroderma Society of Ontario ($50,590 2007 - 2008)

Pilot Study of Once-A-Day Prophylaxis for Youth and Young Adults with Severe Hemophila.  Feldman BM, Rivard G, Carcao M, St-Louis J, Teitel J, Pulleneyegum E, Blanchette V: Bayer Partnership Fund ($250,000 11/2007 – 09/2010)

Estimating Treatment Effects for Uncommon Disease Using Observational Data in a Bayesian Context.  The Warfarin in Scleroderma-pulmonary Hypertension Model.  Feldman BM, Granton J, Hawker G, Johnson S, Krahn M, Tomlinson G:  CIHR / Institute of Musculoskeletal Health & Arthritis ($104,652 04/2009 – 03/2011)

Development of an Internet-based Psycho-educational Program for School-age Children with Arthritis and their Parents: Phase 1.  Stinson J, Feldman, BM, Duffy C, Huber A, Tucker L, McGrath P, Tse S, Hetherington R, Spiegel L, Campillo S, Benseler S: Canadian Arthritis Network ($240,000 04/2009 – 03/2011)

Application of Quantitative Gait and Spinal Analysis towards Improving Outcomes of Patients with Juvenile Spondyloarthropathy.  Tse S, Zabjek K, Laxer R, Feldman BM, Whitney-Mahoney K, Anderson M, Heung E: Spondyloarthritis Research Consortium of Canada ($9,783.94 07/2009 – 07/2010)

Validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) in Children with Spondyloarthropathy.  Tse S, Feldman BM, Laxer R, Anderson M, Whitney K, Marcuz J, Compeyrot-Lacassagne S:  Spondyloarthritis Research Consortium of Canada ($9,841.87 07/2009 –07/2010)

Pharmacogenetics of Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis: The influence of Polymorphisms in Genes of Enzymes Involved in Metabolism on the Efficacy and Toxicity of Methotrexate Therapy: A Pilot Study.  Schmeling H, Feldman BM, Yeung R, Siminovitch K, Miettunen P, Horneff G: Alberta Children’s Hospital Foundation ($45,217 09/2009 – 09/2010)

Comparing the Burdon of Illness of Hemophilia in the Developing and the Developed World:  The Sao Paulo-Toronto Hemophilia Study. Feldman BM, Blanchette V: Baxter Healthcare Corporation (219,637.94 02/2010-02/2013)

Validation of the Children’s International Mucositis Evaluation Scale.  Sung L, Feldman BM:  Canadian Institutes of Health Research (457,898 04/2010-03/2012)

Pharmacogenetics of Juvenile Idiopathic Arthritis – A Genome Wide Association Study on the Efficacy and Toxicity of Methotrexate Therapy.  Schmeling H, Feldman BM, Siminovitch K Benseler S:  Network Centres of Excellence (240,000 04/2010-03/2012)

Towards a Wireless Pain Diary Decision Support System for Youth with Juvenile Idiopathic Arthritis.  Stinson J, Feldman B, Laxer R, Spiegel L, Benseler S, Luca N: Canadian Institutes of Health Research (15,000 10/2010-09/2011)

Canadian Hemophilia Dose Escalation Primary Prophylaxis (CHPS-3) Observational Extension Study.  Feldman BM, Blanchette V,  Rivard GE, Israels S, Chan A, Lillicrap D, Willan A, Einarson T, Babyn P, Doria A, Wintle R:  Bayer Inc. (583,671.71 2010-2012)  

Developing an Interaction-Framework for Dissemination of Knowledge on Imaging Methodology for Assessment of Arthritic Joints: Sustained Positive Impact on Diagnosis and Management of Patients. Doria A, Roth J, Feldman B, Benseler S, White L, Rosenberg A, Miller E, Reed M, Wiebe S, Oen K, Luke B, Babyn P, Gahunia H, Bruns A, Yeung R, Blanchette V, Sussman M, Gagliardi A, Rivard G, Chiu-Poon M, Oritz C. Canadian Arthritis Network (115,000 10/2010-12/2016) (Under Review)

Teens Taking Charge:  An Internet-based Self-management Program for Adolescents with Arthritis:  A Randomized Controlled Trial.  Stinson JN, Feldman BM, Huber A, Chamber C, Spiegel L.  Canadian Institutes of Health Research.  (499,916 04/2010-03/2013)

Achievements

  • Eugenie Stuart Award for Best Instructor.  Faculty of Medicine Department of Health Policy, Management & Evaluation.  University of Toronto.  2011
  • Department of Paediatrics Physician Research Award for Scientific Accomplishment.  University of Toronto.  2007
  • Arthritis Foundation (Alabama Chapter) Outstanding Speaker Award.  2007
  • Canada Research Chair in Childhood Arthritis Tier II, 2007-2012.  2007
  • University of Toronto Department of Paediatric Award for Scientific Merit - 2007
  • James C. Fallis Teaching Award, Runner-up for presentation at PEM Fellows' Rounds.  2004
  • Henry Kunkel Young Investigator Award, American College of Rheumatology.  2004
  • Canada Research Chair in Childhood Arthritis, Tier II, 2002 – 2007. 2002
  • Post-Graduate Excellence in Teaching, PERLS Lecture Series.  1998
  • Ontario Ministry of Health Career Scientist 1995-2002.  1995
  • Clinical Epidemiology Research Award.  University of Toronto.  1994
  • Philip Rosen Research Award. Canadian Rheumatology Association.  1993
  • Children's Hospital of Eastern Ontario - Core - Resident - Resident Research Award - 3rd Year.  1989
  • University of Western Ontario John C. Rathburn Memorial Prize for highest standing in Pediatrics during the Clinical Clerkship.  1985
  • University of Western Ontario Dean's Honour List.  1985
  • University of Western Ontario Benjamin Weidenbaum and Cecelia Rotstein Scholarship for the second highest standing in the Clinical Clerkship.  1985
  • University of Western Ontario Tuition Scholarship. 1979-1981.  1979

Publications

PA-denotes Principal Author; SRI-Senior Responsible Investigator; CPA-Co-Principal Author; C-Collaborator.

  • Akikusa JD, Feldman BM, Gross GJ, Silverman ED, Schneider R: Sinus bradycardia after intravenous pulse methyprednisolone. Pediatrics 2007: 119(3): pp e778-782.  C

 

  • Gong GWK, Young N, Dempster H, Porepa M, Feldman BM: The Quality of My Life (QOML) Questionnaire: The Minimal Clinically Important Difference (MCID) for Pediatric Rheumatology. Journal of Rheumatology 2007: 34(3): pp 581-587.  SRI

 

  • Gong GWK, Barrera M, Beyene J, Bhat S, Carcao M, Lord S, Narayanan U, Sung L, Young N, Feldman BM: The Gap Study (GapS) interview - developing a process to determine the meaning and determinants of quality of life in children with arthritis and rheumatic diseases. Clinical and Experimental Rheumatology 2007: 25(3): pp 486-493.  SRI

 

  • Feldman BM, Aledort L, Bullinger M, Delaney FM, Doria AS, Funk S, Giangrande P, Lundin B, Manco-Johnson M, Miners A, Scriba PC, Sricvastava A, Blanchette VS: The economics of haemophilia prophylaxis: governmental and insurer perspectives.  Proceedings of the Second International Study Group (IPSG) symposium.  Haemophilia 2007: 13(6): pp 745-9.   PA

 

  • Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS: The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.  Rheumatology (Oxford) 2007: 46(10): pp 1606-1611.  C

 

  • Huber AM, Tomlinson GA, Koren G, Feldman BM: Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian meta-analysis of multiple N-of-1 clinical trials.  Journal of Rheumatology 2007: 34(5): pp 1125-1132.  SRI

 

  • Johnson S, Feldman BM, Hawker G: Classification Criteria for Systemic Sclerosis Subsets. Journal of Rheumatology 2007: 34(9): pp 1855-1863.  C

 

  • Johnson SR, Goek O-N, Singh-Grewal D, Vlad SC, Feldman BM, Felson DT: Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis and Rheumatism 2007: 57(7): pp 1119-1133.  C

 

  • Ota S, McLimont M., Carcao M, Blanchette V, Graham N, Paradis E, Feldman BM: Definitions for Haemophilia Prophylaxis and its Outcomes: The Canadian Consensus Study.  Haemophilia 2007: 13(1): pp 12-20.  SRI

 

  • Sarkissian T, Beyene J, Feldman BM, McCrindle B, Silverman ED: Longitudinal Examination of Lipid Profiles in Pediatric Systemic Lupus Erythematosus. Arthritis and Rheumatism 2007: 56(2): pp 631-638.  C

 

  • Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, Silverman ED: Prevalence Risk Factors and Outcome of Uveitis in Juvenile Idiopathic Arthritis. Arthritis and Rheumatism 2007: 56(2): pp 647-657.  C

 

  • Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, Silverman ED: Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor. Arthritis and Rheumatism 2007: 56(6): pp 1974-1984.  C

 

  • Singh-Grewal D, Schneiderman-Walker J, Wright V, Bar-Or O, Beyene J, Selvadurai H, Cameron B, Laxer RM, Schneider R, Silverman ED, Spiegel L, Tse S, LeBlanc C, Wong J, Stephens S, Feldman BM:  The effects of vigorous exercise training on physical function in children with arthritis: a randomized, controlled, single-blinded trial. Arthritis and Rheumatism 2007: 57(7): pp 1202-1210.  SRI

 

  • Stephens S, Singh-Grewal D, Bar-Or O, Beyene J, Cameron B, LeBlanc C, Schneider R, Schniederman-Walker J, Selvadurai H, Silverman ED, Spiegel L, Tse S, Wright V, Feldman BM: Reliability of exercise testing and functional activity questionnaires in children with juvenile arthritis. Arthritis and Rheumatism 2007: 57(8): pp 1446-52.  SRI

 

  • Sung L, Tomlinson GA, Greenberg ML, Koren G, Judd P, Ota S, Feldman BM: Validation of the oral mucositis assessment scale in pediatric cancer. Pediatric Blood Cancer 2007: 49(2): pp 149-153.  SRI

 

  • Sung L, Tomlinson GA, Greenberg ML, Koren G, Judd P, Ota S, Feldman BM: Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatrics patients. European Journal of Cancer 2007: 43(8): pp 1269-1275.  SRI

 

  • Uziel Y, Feldman BM, Krafchik B, Laxer RM, Yeung RSM: Increased serum levels of TGFbeta1 in children with localized scleroderma. Pediatric Rheumatology 2007: 5: pp 22.  C

 

  • Abrahamyan L, Johnson SR, Beyen J, Shah PS, Feldman BM: Quality of randomized clinical trials in juvenile idiopathic arthritis. Rheumatology (Oxford) 2008: 47(5): pp 640-645.  SRI

 

  • Feldman BM, Funk S, Lundin B, Doria AS, Ljung R, Blanchette V: Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG). Haemophilia 2008: 14 (Suppl.) 3: pp 162-169.  PA

 

  • Feldman BM, Rider LG, Reed AM, Pachman LM: Juvenile dermatomyostitis and other idiopathic inflammatory myopathies of childhood. Lancet 2008: 371(9631): pp 2201-2212.  PA

 

  • Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG: Juvenile Dermatomyositis Disease Activity Collaborative Study Group: Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis. Arthritis and Rheumatism 2008: 59(2): pp 214-221.  C

 

  • Manlhiot C, Liang L, Tran D, Bitnun A, Tyrrell PN, Feldman BM: Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. Rheumatology (Oxford) 2008: 47(4): pp 526-529.  SRI

 

  • Manlhiot C, Tyrrell P, Liang L, Atkinson A, Lau W, Feldman BM: Safety of Intravenous Immunoglobulin in the Treatment of Juvenile Dermatomyositis: Adverse Reactions are Associated with Immunoglobulin A Content. Pediatrics 2008: 121(3): pp e626-30.  SRI

 

  • Nicholson A, Berger K, Bohn R, Carcao M, Fischer K, Gringeri A, Hoots K, Mantovani L, Schramm W, Van Hout BA, Willan AR, Feldman BM: Recommendations for reporting economic evaluations of haemophilia prophylaxis: a normal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group. Haemophilia 2008: 14(1): pp 127-132.  SRI

 

  • Pullenayegum E, Lam C, Manlhiot C, Feldman BM: Fitting Marginal Structural Models: Estimating covariate-treatment associations in the reweighted data set can guide model fitting. Journal of Clinical Epidemiology. 2008 61(9): pp 875-81.  SRI

 

  • Risebrough N, Oh P, Blanchette V, Curtin J, Hitzler J, Feldman BM: Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A. Haemophilia 2008: 14(4): pp 743-752.  SRI

 

  • Seshadri R, Feldman BM, Ilowite N, Cawkwell G, Pachman LM: The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis. Arthritis and Rheumatism 2008: 59(7): pp 989-995.  C

 

  • Sharieff W, Zlotkin SH, Ungar WJ, Feldman BM, Krah MD, Tomlinson G: Economics of preventing premature mortality and impaired cognitive development in children through home-fortification: A health policy perspective. International Journal of Technology Assessment in Health Care 2008: 24(3): pp 303-311.  C

 

  • Stephens S, Feldman BM, Bradley N, Schneiderman-Walker J, Wright V, Singh-Grewal D, Lefebvre A, Benseler S, Cameron B, Laxer R, O'Brien C, Schneider R, Silverman ED, Spiegel L, Stinson J, Tyrrell P, Whitney K, Tse S: Feasibility and Effectiveness of an Aerobic Exercise Program in Children with Fibromyalgia, Results of a randomized controlled pilot trial. Arthritis and Rheumatism 2008 59(10): pp 1399-406.  CPA

 

  • Stinson JN, Petroz GC, Stevens BJ, Feldman BM, Streiner D, McGrath PH, Gill N: Working out the kinks: Testing the feasibility of an electronic pain diary for adolescents with arthritis. Pain Research and Management 2008 13(5): pp 375-82.  C

 

  • Stinson JN, Stevens BJ, Feldman BM, Streiner D, McGrath PJ, Dupuis A, Gill N, Petroz GC: Construct validity of a multidimensional electronic pain diary for adolescents with arthritis. Pain 2008: 136(3): pp 281-292.  C

 

  • Stinson JN, Toomey P, Stevens B, Kagan S, Duffy C, Huber A, Malleson P, McGrath P, Yeung R, Feldman BM: Asking the Experts: Exploring the Self-Management Needs of Adolescents with Arthritis. Arthritis and Rheumatism 2008: 59(1): pp 65-72.  SRI

 

  • Stringer E, Singh-Grewal D, Feldman BM: Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis and Rheumatism 2008 58(11): pp 3585-3592.  SRI

 

  • Tomlinson D , Gibson F, Treister N , Baggott C , Judd P , Hendershot E , Maloney A—M, Doyle, Feldman BM, Sung L: Challenges of mucositis assessment in children: Expert opinion. European Journal of Oncology Nursing 2008: 12(5): pp 469-475.  C

 

  • Wijeysundera DN, Feldman BM: Quality, not just quantity: the role of qualitative methods in anesthesia research. Canadian Journal Anaesth. 2008: 55(10): pp 670-673.  SRI

 

  • Ota S, Cron RQ, Schanberg LE, O'Neil K, Mellins ED, Fuhlbrigge RC, Feldman BM: Research Priorities in Pediatric Rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Consensus.  Pediatric Rheumatology 2008: 6(5): pp 1-5.  SRI

 

  • Brunner J, Armstrong D, Feldman BM, Schneider R, Benseler S: Childhood Stroke as the Presentation of Takayasu's Arteritis: Diagnostic Delay can cause Catastrophic Complications. Journal of Rheumatology 2008: 35(6): pp 1228-30.  C

 

  • Benseler SM, Bargman JM, Feldman BM, Tyrrell PN, Harvey E, Hebert D, Silverman ED: Acute renal failure in systemic lupus erythematosus: treatment and outcome. Rheumatology (Oxford) 2009: 48(2): pp 176-182.  C

 

  • Butbul Aviel Y, Tyrrell PN, Schneider R, Dhillon S, Feldman BM , Laxer RM , Saurenmann RK, Spiegel L, Cameron B, Tse SM, Silverman ED: Comparison of Patients with Juvenile Psoriatic Arthritis (JPsA) and Non-psoriatic Juvenile Idiopathic Arthritis (JIA): How Different are They? Journal of Rheumatology 2009: 36(9): pp 2033-41.  C

 

  • Hutzal CE, Wright FV, Stephens S, Schneiderman-Walker J, Feldman BM: A Qualitative Study of Fitness Instructors' Experiences Leading an Exercise Program for Children with Juvenile Idiopathic Arthritis. Physical & Occupational Therapy in Pediatrics 2009: 29(4): pp 409 -425.  SRI

 

  • Nulman I, Rovet J, Barrera M, Knittel-Keren D, Feldman BM, Koren G: Long-term Neurodevelopment of Children Exposed to Maternal Nausea and Vomiting of Pregnancy and Diclectin. Journal of Pediatrics 2009: 155(1): pp 45-50.  C

 

  • Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, Cabral DA, Feldman BM, Tse S, Chédeville G, Spiegel L, Schneider R, Lang B, Ellsworth J, Ramsey S, Dancey P, Silverman E, Chetaille AL, Cameron B, Johnson N, Dorval J, Petty RE, Duffy KW, Boire G, Haddad E, Houghton K, Saint-Cyr C, Turvey SE, Benseler S, Cheang M, Yeung RS, Duffy CM: Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis and Rheumatism 2009: 61(8): pp 1077-86.  C

 

  • Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM, Villalba ML, Myones BL, Pachman LM, Rennebohm RM, Reed AM, Miller F (IMACS Group): Damage Extent and Predictors in Adult and Juvenile Dermatomyositis and Polymyositis as Determined With the Myositis Damage Index.  Arthritis and Rheumatism 2009: 60(11): pp 3425–3435.  C

 

  • Tomlinson D, Gibson F, Treister N, Baggott C, Judd P, Hendershot E,  Maloney AM, Doyle J, Feldman B, Kwong K, Sung L:  Understandability, content validity, and overall acceptability of the Children's International Mucositis Evaluation Scale (ChIMES): child and parent reporting. European Journal of Oncology Nursing. Journal of Pediatric Hematology Oncology 2009 June: 31(6): pp 416-23.  CA

 

  • Tomlinson D, Gibson F, Treister N, Baggott C, Judd P, Hendershot E, Maloney A-M, Doyle J, Feldman BM, Sung L: Designing An Oral Mucositis Assessment Instrument For Use In Children: Generating Items Using A Nominal Group Technique. Supportive Care in Cancer 2009 17(5): pp 555-62.  C

 

  • Johnson SR, Feldman BM, Pope J, Tomlinson G: Shifting our thinking of uncommon disease trials: The case of methotrexate in scleroderma. Journal of Rheumatology 2009: 36(2): pp 323-329.  CPA

 

  • Dugan EM, Huber AM, Miller FW, Rider LG for the International Myositis Assessment and Clinical Studies (IMACS) Group:  Photoessay of the cutaneous manifestations of the idiopathic inflammatory Myopathies. Dermatology Online Journal 2009: 15(2): article 1.  C

 

  • Dugan EM, Huber AM, Miller FW, Rider LG for the International Myositis Assessment and Clinical Studies (IMACS) Group: Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory Myopathies.  Dermatology Online Journal 2009: 15(2): article 2.  C

 

  • Globe D, Young NL, Von Mackensen S, Bullinger M, Wasserman J; Healthrelated Quality of Life Expert Working Group of The International Prophylaxis Study Group: Measuring Patient-reported Outcomes in Haemophilia Clinical Research. Haemophilia 2009: 15(4): pp 843-852.  C

 

  • Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O'Neil KM: Treatment of Pediatric Localized Scleroderma: Results of a Survey of North American Pediatric Rheumatologists. Journal of Rheumatology 2010 Jan: 37(1): pp 175-81.  C

 

  • Tomlinson D, Gibson F, Treister N, Baggott C, Judd P, Hendershot E, Maloney A, Doyle J, Feldman BM, Kwong K, Sung L:  Refinement of the Children's International Mucositis Evaluation Scale (ChIMES): child and parent perspectives on understandability, content validity and acceptability. European Journal of Oncology Nursing 2010 Feb: 14(1): pp 29-41.  C

 

  • Huber AM, Giannini EH, Bowyer SL, Kim S, Lang B, Lindsley CB, Pachman LM, Pilkington C, Reed AM, Rennebohm RM, Rider LG, Wallace CA, Feldman BM: Protocols for the Initial Treatment of Moderately Severe Juvenile Dermatomyositis: Results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Research (Hoboken) 2010 Feb: 62(2): pp 219-25.  SRI

 

  • Johnson SR, Tomlinson GA, Hawker GA, Granton JT, Grosbein HA, Feldman BM: A Valid and Reliable Belief Elicitation Method for Bayesian Priors.Journal of Clinical Epidemiology 2010 Apr: 63(4): pp 370-383 SRI

 

  • Johnson SR, Tomlinson GA, Hawker GA, Granton JT, Feldman BM: Methods to Elicit Beliefs for Bayesian Priors: A Systematic Review. Journal of Clinical Epidemiology 2010 Apr: 63(4): pp 355-369.  SRI

 

  • Stinson J, Stevens B, Feldman B, Streiner D, McGrath P, Dupuis A, Petroz G, Gill N:  Using an Electronic Pain Diary to Better Understand Pain in Children and Adolescents with Arthritis. Pain Research & Management 2011 Mar: 1(2): pp 127-137(11).  C

 

  • Feldman B, Funk SM, Bergstrom BM, Zourikian N, Hilliard P, van der Net J, Engelbert R, Petrini P, van den Berg HM, Manco-Johnson MJ, Rivard GE, Abad A, Blanchette VS:  Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: Validity of the hemophilia joint health score. Arthritis Care & Research 2011 Feb: 63(2): pp 223-230.  PA
  • Johnson SR, Granton JT, Tomlinson GA, Grosbein HA, Hawker GA, Feldman BM: Effect of Warfarin on Survival in Scleroderma-associated Pulmonary Arterial Hypertension (SSc-PAH) and Idiopathic PAH. Belief Elicitation for Bayesian Priors. The Journal of Rheumatology 2011 Mar: 38(3): pp 462–469.  SRI

 

  • Batthish M, Feldman BM: Juvenile Dermatomyositis. Current Rheumatology Reports. 2011: 13: pp 216–224.  SRI

 

  • Batthish M, Feldman BM, Babyn PS, Tyrrell PN, Schneider R: Predictor of Hip Disease in the Systemic Arthritis Subtype of Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 2011 May: 38(5):  pp 954-958.  C

 

  • Butbul Y, Stremler R, Benseler SM, Cameron B, Laxer RM, Ota S, Schneider R, Spiegel L, Stinson JN, Tse SML, Feldman BM: Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. August 2011. (doi:10.1093/rheumatology/ker256).  SRI 

 

  • Lam C, Manlhiot C, Pullenayegum E, Tyrrell PN, Feldman BM: Efficacy of Intravenous Immunoglobulin Therapy in Juvenile Dermatomyositis. Annals of the Rheumatic Diseases. Published online October 6, 2011. (doi:10.1136/ard.2011.153718).  C